Repairing full-thickness articular cartilage defects with homograft of mesenchymal stem cells seeded onto cancellous demineralized bone matrix
同种异体脱钙松质骨基质材料复合自体骨髓间充质干细胞修复全层关节软骨缺损
查看参考文献22篇
|
文摘
|
BACKGROUND: Up to now, no universally successful therapy to treat substantial articular cartilage defects has been available. Numerous therapeutic approaches can only improve clinical symptoms of joint lesions, but not stimulate the regenerative and reactive capacity of the biological tissue in the defect, and not restore an articular surface capable of functional load bearing. OBJECTIVE: To investigate the curative effects of homograft of mesenchymal stem cells (MSCs) seeded onto cancellous demineralized bone matrix (DBM) on articular cartilage defects. DESIGN, TIME AND SETTING: A randomized controlled study which conducted in Orthopaedics Institute, the Second Hospital of Lanzhou University from January to March 2005 and Central Laboratory of Guilin Medical Collage from May to August 2008. MATERIALS: Bone metaphysis and vertebral cancellous bone were derived from rabbits to prepare DBM materials. MSCs were seed on DBM stent and cultured in vitro. All 36 rabbits were randomly divided into combination group (DBM/MSCs), DBM alone group, and blank control group, with 12 rabbits per group. METHODS: Full-thickness cartilage defect model of knee joint was frilled using a cylinder of 4 mm diameter and 3 mm thickness on intercondylar fossa. The cartilage defects in the intercondylar fossa were filled with MSCs/DBM in combination group A, with only DBM in the DBM group, and nothing was treated in the blank control group. MAIN OUTCOME MEASURES: Four rabbits were killed at three time points, which were 4, 8 and 12 weeks after the operation in each group, and the reparative tissue samples were evaluated grossly, histologically, immunohistochemically and graded according to gross and histological scale. RESULTS: Tirty-six rabbits were included in the final analysis. The defects of MSCs/DBM transplantation were repaired by hyline-like tissue, and the other defects were repaired by fibrous tissue. Gross and histological grading scale was made on 12 weeks postoperatively. Gross and histological scores in the MSCs/DBM group were significantly lower than DBM group and control group (P < 0.05); while, the scores in the DBM group was significantly lower than control group (P < 0.05). CONCLUSION: The full-thickness cartilage defects of rabbits were repaired with homograft of mesenchymal stem cells seeded onto cancellous demineralized bone matrix, which is a promising way for the treatment of cartilage defects. |
|
其他语种文摘
|
背景:到目前为止,还没有一种十分有效的方法治疗关节软骨缺损。许多治疗方法都只能缓解临床症状,而不能有效促进软骨的再生,也不能恢复软骨表面的承重功能。目的:观察脱钙骨基质复合骨髓间充质干细胞修复兔膝关节全层软骨缺损的疗效。设计、时间及地点:随机对照动物实验,分别于 2005-01/03 在兰州大学第二医院骨科研究所和 2008-05/08 在桂林医学院中心实验室完成。材料:取新西兰兔四肢骨干骺端及椎体松质骨,脱钙制备脱钙松质骨基质材料;体外分离培养同种新西兰兔骨髓间充质干细胞种植于脱钙骨基质支架上体外培养。36 只新西兰兔随机分成骨髓间充质干细胞复合同种异体脱钙骨填充组(简称复合组)、同种异体脱钙骨填充组及空白对照组,每组 12 只。方法:在髁间窝髌面上用直径 4 mm 的钻头钻孔深约 3 mm 造成膝关节全层软骨缺损模型。复合组双侧股骨髁间窝软骨缺损处植入脱钙骨基质吸附体外分离培养的自体骨髓间充质干细胞复合物;同种异体脱钙骨填充组单纯植入脱钙骨基质;空白对照组不作任何植入。主要观察指标:分别于植入后 4,8,12 周取材进行组织学及免疫组化染色观察,根据关节软骨组织学计分标准进行评分。结果:36 只新西兰兔均进入结果分析。复合组所修复组织为透明软骨样修复;而同种异体脱钙骨填充组和空白对照组为纤维性修复。植入后 12 周复合组大体评分及组织学评分明显低于同种异体脱钙骨填充组和空白对照组(P < 0.05);同种异体脱钙骨填充组低于空白对照组(P < 0.05)。结论:运用软骨组织工程的原理,以脱钙骨基质为支架材料的自体骨髓间充质干细胞移植是一种修复软骨缺损的行之有效的方法。 |
|
来源
|
中国组织工程研究与临床康复
,2008,12(45):8943-8947 【扩展库】
|
|
关键词
|
homograft of mesenchymal stem cells
;
articular cartilage defects
;
bone matrix
|
|
地址
|
1.
Department of Orthopaedics, the Affiliated Hospital of Guilin Medical University, Guangxi Zhuang Autonomous Region, Guilin, 541001
2.
Institute of Orthopaedics, the Second Hospital of Lanzhou University, Gansu, Lanzhou, 730030
|
|
语种
|
英文 |
|
文献类型
|
研究性论文 |
|
ISSN
|
1673-8225 |
|
学科
|
临床医学 |
|
基金
|
the grants from Guangxi Administration Bureau of Public Health Program, No. Z2007211
|
|
文献收藏号
|
CSCD:3464655
|
参考文献 共
22
共2页
|
|
1.
The Ministry of Science and Technology of the People's Republic of China.
Regulations for the Administration of Affairs Concerning Experimental Animals,1988
|
被引
73
次
|
|
|
|
|
2.
O'Driscoll SW. Chondrogenesis in periosteal explants. An organ culture model for in vitro study.
J Bone Joint Surg Am,1994,76(7):1042-1051
|
被引
6
次
|
|
|
|
|
3.
Ferkel RD. Arthroscopic treatment of chronic osteochondral lesions of the talus:long-term results.
Am J Sports Med,2008,36(9):1750-1762
|
被引
6
次
|
|
|
|
|
4.
Cook JL. Autogenous osteochondral grafting for treatment of stifle osteochondrosis in dogs.
Vet Surg,2008,37(4):311-321
|
被引
2
次
|
|
|
|
|
5.
Shim IK. Healing of articular cartilage defects treated with a novel drug-releasing rod-type implant after microfracture surgery.
J Control Release,2008,129(3):187-191
|
被引
1
次
|
|
|
|
|
6.
Neumann K. Chondrogenic differentiation capacity of human mesenchymal progenitor cells derived from subchondral cortico-spongious bone.
J Orthop Res,2008,26(11):1449-1456
|
被引
3
次
|
|
|
|
|
7.
Koga H. Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis:suitable conditions for cell therapy of cartilage defects in rabbit.
Cell Tissue Res,2008,333(2):207-215
|
被引
11
次
|
|
|
|
|
8.
Kuroda R. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells.
Osteoarthritis Cartilage,2007,15(2):226-231
|
被引
14
次
|
|
|
|
|
9.
Csaki C. Chondrogenesis, osteogenesis and adipogenesis of canine mesenchymal stem cells:a biochemical, morphological and ultrastructural study.
Histochem Cell Biol,2007,128(6):507-520
|
被引
6
次
|
|
|
|
|
10.
Nadri S. Isolation murine mesenchyrnal stem cells by positive selection.
Vitro Cell Dev Biol Anim,2007,43:276-282
|
被引
6
次
|
|
|
|
|
11.
Chang F. Repair of large full-thickness articular cartilage defects by transplantation of autologous uncultured bone-marrow-derived mononuclear cells.
J Orthop Res,2008,26(1):18-26
|
被引
5
次
|
|
|
|
|
12.
Zhou XZ. Mesenchymal stem cell-based repair of articular cartilage with polyglycolic acid-hydroxyapatite biphasic scaffold.
Int J Artif Organs,2008,31(6):480-489
|
被引
4
次
|
|
|
|
|
13.
Fan H. Porous gelatin-chondroitin-hyaluronate tri-copolymer scaffold containing microspheres loaded with TGF-beta1 induces differentiation of mesenchymal stem cells in vivo for enhancing cartilage repair.
J Biomed Mater Res A,2006,77(4):785-794
|
被引
14
次
|
|
|
|
|
14.
Kose GT. Tissue engineered cartilage on collagen and PHBV matrices.
Biomaterials,2005,26(25):5187-5197
|
被引
10
次
|
|
|
|
|
15.
Gao J. Osteochondral defect repair by demineralized cortical bone matrix.
Clin Orthop Relat Res,2004,427(427 Suppl):S62-S66
|
被引
6
次
|
|
|
|
|
16.
Song HX. Repairing articular cartilage defects with tissue-engineering cartilage in rabbits.
Chin J Traumatol,2006,9(5):266-271
|
被引
9
次
|
|
|
|
|
17.
Park H. Delivery of TGF-beta1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications.
Biomaterials,2005,26(34):7095-7103
|
被引
7
次
|
|
|
|
|
18.
Guo X. Repair of full-thickness articular cartilage defects by cultured mesenchymal stem ceils transfected with the transforming growth factor beta1 gene.
Biomed Mater,2006,1(4):206-215
|
被引
10
次
|
|
|
|
|
19.
Guo CA. Novel gene-modified-tissue engineering of cartilage using stable transforming growth factor-beta1-transfected mesenchymal stem cells grown on chitosan scaffolds.
J Biosci Bioeng,2007,103(6):547-556
|
被引
5
次
|
|
|
|
|
20.
Fan H. Comparison of chondral defects repair with in vitro and in vivo differentiated mesenchymal stem cells.
Cell Transplant,2007,16(8):823-832
|
被引
6
次
|
|
|
|
|
了解气象卫星更多信息，请访问